Edition:
United Kingdom

DelMar Pharmaceuticals Inc (DMPI.OQ)

DMPI.OQ on NASDAQ Stock Exchange Capital Market

0.55USD
8:00pm GMT
Change (% chg)

$0.03 (+5.89%)
Prev Close
$0.52
Open
$0.52
Day's High
$0.57
Day's Low
$0.52
Volume
282,917
Avg. Vol
34,957
52-wk High
$1.38
52-wk Low
$0.28

About

DelMar Pharmaceuticals, Inc. is a clinical-stage drug development company. The Company focuses on the treatment of cancer. The Company is engaged in conducting clinical trials in the United States with its product candidate, VAL-083, as a treatment for glioblastoma multiforme (GBM), a form of brain cancer. VAL-083 is being... (more)
No analyst recommendations are available for .

Overall

Beta: 1.65
Market Cap(Mil.): $13.29
Shares Outstanding(Mil.): 25.59
Dividend: --
Yield (%): --

Financials

  DMPI.OQ Industry Sector
P/E (TTM): -- 5.84 19.38
EPS (TTM): -0.40 -- --
ROI: -142.84 2.04 0.38
ROE: -10,211.63 3.46 16.14

Earnings vs. Estimates